1. Home
  2. HYFT vs OKYO Comparison

HYFT vs OKYO Comparison

Compare HYFT & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HYFT

MindWalk Holdings Corp.

N/A

Current Price

$1.40

Market Cap

69.6M

Sector

Health Care

ML Signal

N/A

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

HOLD

Current Price

$1.78

Market Cap

79.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYFT
OKYO
Founded
1983
2007
Country
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.6M
79.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HYFT
OKYO
Price
$1.40
$1.78
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
422.4K
397.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$51.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$1.03
52 Week High
$3.25
$3.35

Technical Indicators

Market Signals
Indicator
HYFT
OKYO
Relative Strength Index (RSI) 35.27 41.05
Support Level $1.36 $1.55
Resistance Level $1.65 $2.23
Average True Range (ATR) 0.15 0.22
MACD -0.04 -0.03
Stochastic Oscillator 6.90 23.58

Price Performance

Historical Comparison
HYFT
OKYO

About HYFT MindWalk Holdings Corp.

MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Share on Social Networks: